Māori and Pacific families’ experiences and perspectives of cardiovascular care; A qualitative study
Australian and New Zealand Journal of Public Health, Volume 48, June 2024
The paper assesses the feasibility of using the Canadian Health Measures Survey (CHMS) data to analyze chemical exposures in racial and Indigenous populations in Canada, and discusses the opportunities and constraints of this analysis, while noting the limited representativeness of Indigenous identity groups in the CHMS sample.
Review evidence on the burden of chronic respiratory diseases in Indigenous peoples globally, summarise factors that underlie health disparities between Indigenous and non-Indigenous people, propose a framework of approaches to improve the respiratory health of Indigenous peoples, and outline future directions for clinical care and research
Metabolic Steatotic Liver Disease: Current Knowledge, Therapeutic Treatments, and Future Directions, 2024, Pages 261-275
This content aligns with Goal 3: Good Health as this chapter will review the aspects of combined viral hepatitis and FLD, including prevalence, risk factors, natural history, pathogenesis, and management to help inform the reader of the complexity of these liver diseases.
Resilient Health: Leveraging Technology and Social Innovations to Transform Healthcare for COVID-19 Recovery and Beyond, 2024, pp 955-971
Resilient Health: Leveraging Technology and Social Innovations to Transform Healthcare for COVID-19 Recovery and Beyond, 2024, Pages 713-727
Resilient Health: Leveraging Technology and Social Innovations to Transform Healthcare for COVID-19 Recovery and Beyond, 2024, pp 71-87
Resilient Health: Leveraging Technology and Social Innovations to Transform Healthcare for COVID-19 Recovery and Beyond, 2024, pp 1085-1098
Tryptamine Microbiota-Deregulated Aminoacyl-tRNA Biosynthesis: A Conceptual Evolution of the Role of Microbiota Tryptamine in Human Diseases, 2024, pp 253-267
This content aligns with Goal 3: Good Health and Wellbeing and Goal 9: Industry, Innovation, and Infrastructure by highlighting the data demonstrating the role tryptamine plays in Alzheimer's Disease.